Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shouldn't Hoffman

Shouldn't Hoffman

posted on Jan 19, 2007 04:32AM
do more for us on the PR front?  With our potential, and our PE of 8 and change, you would think they could attract more buyers for the stock.  It would help absorb S&L's shares and prop up our pps during this transitional period.  JMO of course.
Share
New Message
Please login to post a reply